CNR1 anticorps (Extracellular, N-Term)
Aperçu rapide pour CNR1 anticorps (Extracellular, N-Term) (ABIN7043023)
Antigène
Voir toutes CNR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 84-99, Extracellular, N-Term
-
Fonction
- A Rabbit Polyclonal Antibody to Cannabinoid Receptor 1
-
Réactivité croisée
- Humain, Souris, Rat
-
Homologie
- Human - identical, mouse - 15,16 amino acid residues identical
-
Attributs du produit
- Anti-Cannabinoid Receptor 1 (extracellular) Antibody (ABIN7043023, ABIN7044155 and ABIN7044156) is a highly specific antibody directed against an epitope of the rat CB1 receptor. The antibody can be used in western blot, immunohistochemistry, and live cell imaging applications. It has been designed to recognize CB1 in human, mouse, and rat samples.
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogène
- NKSLSSFKENEENIQC, corresponding to amino acid residues 84-99 of rat CB1 receptor
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:200
FC: 2.5 μg per reaction
ICC: The optimal concentration should be determined by the user
IHC: 1:100
IP: The optimal concentration should be determined by the user
-
Commentaires
-
Cited Application: IHC
Negative Control: (ABIN7235028)
Blocking Peptide: (ABIN7235028)
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.
-
Concentration
- 0.8 mg/mL
-
Buffer
- PBS pH 7.4, 1 % BSA with 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
-
-
- CNR1 (Cannabinoid Receptor 1 (CNR1))
-
Autre désignation
- CNR1
-
Sujet
-
Synonyms: CB1, CB-R, CNR1, CB1R, CANN6, Brain-type cannabinoid receptor, Central cannabinoid receptor
Description: Cannabinoids have been used in Eastern medicine for many years as pain relievers.1 Δ9-tetrahydrocannabinol (THC), the major psychoactive compound in marijuana and hashish, has been shown to interact with two specific cannabinoid receptors: cannabinoid receptor 1 (CB1 receptor) and cannabinoid receptor 2 (CB2 receptor).2 The cannabinoid receptors can be distinguished by their amino acid sequences, signaling mechanisms, and tissue distributions.2 Both receptors belong to the G-protein coupled receptor (GPCR) superfamily. CB1 was shown to modulate several Ca2+ and K+ ion channels.2,3CB1 is primarily expressed in the central nervous system. However, expression of CB1 is also detected in the peripheral terminals, in non-neuronal peripheral tissues such as uterus, testes, spleen, as well as in cells of the immune system.3,4CB1 is implicated in many cellular functions such as neurotransmitter release, pain relief, cancer, and obesity.5,6 Growth inhibition of tumor cells was demonstrated following mixed CB1/CB2 agonist treatment in both prostate and non-melanoma skin cancers.5,6 Through their interaction with CB1, cannabinoid compounds stimulate appetite for sweets and palatable foods in particular, making CB1 an attractive therapeutic target for the treatment of obesity and eating disorders.7
-
ID gène
- 25248
-
NCBI Accession
- NM_001160226
-
UniProt
- P20272
-
Pathways
- Feeding Behaviour
Antigène
-